Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy
Dalton Transactions · 2025
DOI: 10.1039/d5dt00194c ↗Kurz gefasst
Fachartikel in der Zeitschrift Dalton Transactions, 2025. Verfasst von Thomas Scattolin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze Chimiche, Università degli Studi di Padova, via Marzolo 1, 35131 Padova, Italy. thomas.scattolin@unipd.it. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Palladium, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Bijzonder Onderzoeksfonds, Fonds Wetenschappelijk Onderzoek, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
High-Grade Serous Ovarian Cancer (HGSOC) is the most common and lethal subtype of ovarian cancer, known for its high aggressiveness and extensive genomic alterations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dipartimento di Scienze Chimiche, Università degli Studi di Padova, via Marzolo 1, 35131 Padova, Italy. thomas.scattolin@unipd.it.
- Dipartimento di Scienze Molecolari e Nanosistemi, Università Ca' Foscari, Campus Scientifico Via Torino 155, 30174 Venezia-Mestre, Italy. fvise@unive.it.
- Pathology Unit, Centro di Riferimento Oncologico di Aviano (C.R.O.) IRCCS, via Franco Gallini 2, 33081, Aviano, Italy.
- Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, via Franco Gallini 2, 33081, Aviano, Italy.
- Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, 1000, Slovenia.
- ChimieParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005, Paris, France.
ORCID-Profile: Thomas Scattolin, Giovanni Tonon, Simona Kranjc Brezar, Maria Dalla Pozza, Vincenzo Canzonieri, Nicola Demitri, Steven P Nolan, Gilles Gasser, Fabiano Visentin, Flavio Rizzolio
Förderung
- Bijzonder Onderzoeksfonds
- Fonds Wetenschappelijk Onderzoek
- Associazione Italiana per la Ricerca sul Cancro
- Ministero della Salute
Zitieren
APA
Scattolin, T., Cavarzerani, E., Alessi, D., Mauceri, M., Botter, E., Tonon, G., Caligiuri, I., Repetto, O., Kamensek, U., Brezar, S. K., Dalla Pozza, M., Palazzolo, S., Cemazar, M., Canzonieri, V., Demitri, N., Nolan, S. P., Gasser, G., Visentin, F., & Rizzolio, F. (2025). Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy. Dalton Transactions. https://doi.org/10.1039/d5dt00194c
Vancouver
Scattolin T, Cavarzerani E, Alessi D, Mauceri M, Botter E, Tonon G, et al. Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy. Dalton Transactions. 2025. doi:10.1039/d5dt00194c
BibTeX
@article{Scattolin2025,
author = {Scattolin, Thomas and Cavarzerani, Enrico and Alessi, Dario and Mauceri, Matteo and Botter, Eleonora and Tonon, Giovanni and Caligiuri, Isabella and Repetto, Ombretta and Kamensek, Urska and Brezar, Simona Kranjc and Dalla Pozza, Maria and Palazzolo, Stefano and Cemazar, Maja and Canzonieri, Vincenzo and Demitri, Nicola and Nolan, Steven P and Gasser, Gilles and Visentin, Fabiano and Rizzolio, Flavio},
title = {Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy},
journal = {Dalton Transactions},
year = {2025},
doi = {10.1039/d5dt00194c}
}
EUVIMED